Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications assessment therapy changes drug discontinuation among crohns disease patients using
… Antidepressant Drug Utilization Study Antidepressant Use in Denmark, … , Johan Reutfors Transcript: Antidepressants are among the most prescribed drugs in Europe. However, no … In the framework of a collaborative study, we conducted a drug utilization study in 5 databases in Denmark, Germany, …
… This hormonal excess results in tissue growth, including changes to facial features. As the condition progresses, many … on developing an Acromegaly Symptom Diary (ASD) to help patients with acromegaly capture their experiences with … outcomes (PROs) and are a major focus of ongoing drug development. The US Food and Drug Administration (FDA) …
… include: Highlights and Overview Product Information and Disease Description Clinical Evidence Economic Information … which allow your chosen clinical expert to present key disease and unmet need evidence to US health care decision … helps make new medications and devices available for patients as rapidly as possible. AMCP Approved Product …
… Research Let us help you ensure the safety of your patients by examining and understanding disease indicators and using real-world evidence to support … Dr. Alicia Gilsenan – Member of the Program Committee of Drug Information Association (DIA) , Adjunct Professor, …
… tradeoffs they are willing to make for a potential new therapy, and use that information in designing a clinical … Research (MJFF). RTI will perform the benefit-risk assessment with the Parkinson’s patients that are … science and technology and to enhance trust and confidence among stakeholders. We work in the pre-competitive space to …
… Multi-Criteria Decision Analysis Most drug development and commercialization choices are complex. … Market Access and Post-Approval Decisions From making drug development decisions, to phase III evidence plans, to … Often it is important to understand the balance that patients and other decision makers are willing to strike …
… Drug Safety in Pregnancy Satisfy Regulatory Requirements With … treat conditions related to pregnancy. If you have a new drug, biologic, vaccine, or medical device entering the … studies that make secondary use of existing data sources—using real-world data to generate real-world evidence (RWE). …
… Health Technology Assessment (HTA) Utility Measures: Not One-Size-Fits-All HTA … Státní Ústav pro Kontrolu Léčiv [State Institute for Drug Control] EQ-5D (recommended or preferred MAUI). “A … to EQ-5D values using validated methods. • To account for changes in morbidity and mortality in the general population …
… centralise the clinical domains of the health technology assessment (HTA) process on a European-wide level. The 4 … (background information on patient population, burden of disease, comparators and their use); technical (description … that access to innovative medicines is accelerated for EU patients in the EU. Whether the new legislation and …
… 2019 Watch the recording When seeking approval for rare disease products, demonstrating value for therapies can be a … meet good practice recommendations for health technology assessment submissions. Join us for this webinar where our … for rare disease research that can help you gain orphan drug reimbursement. View this webinar where you’ll learn: …